TITLE

ETHYL LINOLEATE AS AN ANTIATHEROGENIC AGENT

AUTHOR(S)
Datey, K.K.; Purandare, N.M.; Dalvi, C.P.
PUB. DATE
October 1966
SOURCE
Angiology;Oct1966, Vol. 17 Issue 10, p732
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
1. Seventy-eight rabbits were fed diets containing varying proportions of cholesterol (0.5 to 4 per cent). 2. Half of the rabbits served as controls, while ethyl linoleate was administered to the rest. 3. There was no evidence of arteriosclerosis in any of the treated animals. 4. Histopathologic changes in the heart and liver were more frequent in the control group than in these treated with ethyl linoleate. 5. The possible mode of action of ethyl linoleate is discussed.
ACCESSION #
16378117

 

Related Articles

  • Conjugated linoleic acid and atherosclerosis: studies in animal models. Mitchell, Patricia L.; McLeod, Roger S. // Biochemistry & Cell Biology;Aug2008, Vol. 86 Issue 4, p293 

    Conjugated linoleic acids (CLA) are isomeric forms of linoleic acid (LA) containing two conjugated sites of unsaturation. The most abundant dietary form of CLA is the cis-9,trans-11 (c-9,t-11) isomer that is found in the fatty tissues and milk of ruminant animals. CLA can also be acquired by...

  • CONJUGATED LINOLEIC ACID. Drozd, Shelley // Runner's World;Sep2005, Vol. 40 Issue 9, p48 

    Presents information on conjugated linoleic acid, a type of fat found primarily in milk and cattle meat.

  • CLA.  // Muscle & Performance;Sep2011, Vol. 3 Issue 9, p26 

    The article offers information on a study which examined the beneficial properties of conjugated linoleic acid (CLA) despite the fact that it is a trans-fatty acid.

  • A New Perspective on trans,trans Conjugated Linoleic Acid (CLA), an Overlooked CLA Isomer. Shah, Utkarsh; Baum, Jamie; Proctor, Andrew // Journal of the American Oil Chemists' Society (JAOCS);Mar2014, Vol. 91 Issue 3, p521 

    A letter to the editor is presented on the health benefits of trans, trans conjugated linoleic acid (CLA).

  • The metabolism of linoleic acid in healthy subjects after intake of a single dose of 13C-linoleic acid. Vermunt, S.H.F.; Mensink, R.P.; Simonis, M.M.G.; Wagenmakers, A.J.M.; Hornstra, G. // European Journal of Clinical Nutrition;May2001, Vol. 55 Issue 5, p321 

    Presents a study which examined the oxidation of C linoleic acid and its conversion into longer chain polyunsaturated fatty acids in normal healthy adults. Overview of the metabolism of linoleic acid; Methods used in the study; Results; Conclusions.

  • Keep the fat off.  // Prevention;Sep2005, Vol. 57 Issue 9, p78 

    Presents the results of a Norwegian study on the health benefits of conjugated linoleic acid. How a daily dose of this acid helped people maintain a 9 percent body-fat loss that they'd achieved during previous years; Speculation that the lean muscle mass they retained may have kept their...

  • NEWER CONCEPTS IN ATHEROSCLEROSIS: SUBLINGUAL HEPARIN. Loewe, Leo; Halpern, Alfred // Angiology;Apr1961, Vol. 12 Issue 4, p117 

    Comments on the new clinical diagnosis of atherosclerosis, a formation of atheromas. Common term of the disease; Symptoms of the disease; Cause of the disease.

  • Incidence of and Risk Factors for Asymptomatic Peripheral Arterial Occlusive Disease: A Longitudinal Study. Hooi, Jurenne D.; Kester, Arnold D. M.; Stoffers, Henri E. J. H.; Overdijk, Marjori M.; Ree, Jan W. van; Knottnerus, J. André // American Journal of Epidemiology;Vol. 153 Issue 7, p666 

    The current study describes the age- and sex-specific incidence rates and risk factors for asymptomatic and symptomatic peripheral arterial occlusive disease (PAOD) among 2,327 subjects and the incidence of intermittent claudication in asymptomatic PAOD subjects. The study population was...

  • Elucidating atherosclerotic vulnerable plaque rupture by modeling cross substitution of ApoE mouse and human plaque components stiffnesses. Ohayon, Jacques; Mesnier, Nicolas; Broisat, Alexis; Toczek, Jakub; Riou, Laurent; Tracqui, Philippe // Biomechanics & Modeling in Mechanobiology;Jul2012, Vol. 11 Issue 6, p801 

    The structure of mouse atherosclerotic lesions may differ from that of humans, and mouse atherosclerotic plaques do not rupture except in some specific locations such as the brachiocephalic artery. Recently, our group was the first to observe that the amplitudes of in vivo stresses in ApoE mouse...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics